ZL-1102 3% w/w gel QD for 16 weeks

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque PsoriasisNCT06380907Zai Lab (Hong Kong), Ltd.Phase 2Terminated2025-12-16Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.